China yuan's trade-weighted value falls to near two-year low
SHANGHAI: The Chinese yuan's value against its major trading partners fell close to a two-year low on Friday, reflecting the central bank's efforts to keep it steady versus the US dollar even as other currencies rise sharply.
WHY IT'S IMPORTANT
The People's Bank of China (PBOC) has been carefully managing its currency, allowing only marginal appreciation against the dollar even as other major and Asian currencies rally against a weakening US currency.
The policy, done through keeping the daily official yuan midpoint guidance steady, is expected to protect exporters during an ongoing trade war by offsetting tariffs with better currency conversion rates for their revenues.
A steadier yuan will also ensure there is no chaotic rush by corporates and households to sell their nearly US$1 trillion in foreign exchange deposits.
While Beijing has said it does not deliberately seek a weaker currency, the currency's passive decline comes at a time of heightened Sino-US tensions for an economy struggling with deflationary pressures and weak domestic demand.
BY THE NUMBERS
The CFETS yuan index, a gauge that measures the yuan's weighted value versus 25 currencies of trading partners, fell to 95.58 and is down 5.8 per cent year-to-date, according to Reuters calculations based on official data.
The yuan has, however, strengthened 1.6 per cent versus the dollar during the same period.
The official yuan midpoint has barely changed and is up about 0.05 per cent this year.
KEY QUOTES
Goldman Sachs estimated that a 10 per cent yuan depreciation in trade-weighted terms could increase goods exports by 5 per cent with a one-quarter lag, equivalent to a an increase of 75-basis-point GDP growth impulse.
"A greater than 5 per cent decline in CFETS within five months may be too fast and a further dip below 95 could fuel concerns or even some hostility from other Asian trading partners," Barclays analysts said in a note.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
3 hours ago
- Malaysian Reserve
DNUT Deadline: DNUT Investors with Losses in Excess of $100K Have Opportunity to Lead Krispy Kreme, Inc. Securities Fraud Lawsuit
NEW YORK, June 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the 'Class Period'), of the important July 15, 2025 lead plaintiff deadline. So what: If you purchased Krispy Kreme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Krispy Kreme class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 15, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) demand for Krispy Kreme products declined materially at McDonald's locations after the initial marketing launch; (2) demand at McDonald's locations was a driver of declining average sales per door per week; (3) the partnership with McDonald's was not profitable; (4) the foregoing posed a substantial risk to maintaining the partnership with McDonald's; (5) as a result, Krispy Kreme would pause expansion into new McDonald's locations; and (6) as a result of the foregoing, defendants' positive statements about Krispy Kreme's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Krispy Kreme class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Kim, Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827case@
Malaysian Reserve
3 hours ago
- Malaysian Reserve
ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit
NEW YORK, June 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the 'Class Period'), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Elevance Health class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that, with the Medicaid redetermination process nearly complete, defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in Elevance's guidance for the year. These representations were materially false or misleading. In truth, the redeterminations were causing the acuity and utilization of Elevance's Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs. This shift was occurring to a degree that was not reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Elevance class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Kim, Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827case@
The Star
6 hours ago
- The Star
China-Laos Railway sees over 10 billion yuan in trade value from Jan-May
KUNMING (Xinhua): The China-Laos Railway handled more than 2.48 million tonnes of import and export cargo valued at over 10 billion yuan (US$1.4 billion) from January to May this year, customs data has showed . Both freight volume and value saw significant growth in this period, with a 7.9-per cent year-on-year increase in volume and a 33.2-per cent surge in value. In May alone, this railway transported 512,000 tonnes of goods worth 3.76 billion yuan -- setting a monthly record high since its opening in December 2021. Following its launch, the railway has experienced robust growth in cargo transport. As of May 22, total freight volume had surpassed 60 million tonnes, with cross-border shipments exceeding 13.9 million tonnes. The range of goods transported has expanded dramatically from just over 10 types initially to more than 3,000. These goods include electronics, photovoltaic products, communication equipment, automobiles, agricultural products, industrial goods and daily necessities. - Xinhua
